Join the Oncology
Community
Follow Us:  

Treatment-Related Side Effects

Feasibility and Acceptance of a Telehealth Intervention to Promote Symptom Management during Treatment for Head and Neck Cancer

02/13/11

Bookmark and Share


Submitting your vote...
Not rated yet. Be the first who rates this item!
Click the rating bar to rate this item.

Outcomes research

Feasibility and Acceptance of a Telehealth Intervention to Promote Symptom Management during Treatment for Head and Neck Cancer

Barbara A. Head PhD, RN, CHPN, ACSWCorresponding Author Contact Information, a, E-mail The Corresponding Author, Cynthia Keeney RN, MSNa, Jamie L. Studts PhDa, Mamdouh Khayata, medical student, Jeffrey Bumpous MDa and Mark Pfeifer MDa

a University of Louisville School of Medicine, Louisville; Department of Behavioral Science, University of Kentucky College of Medicine, Lexington; and Veterans Administration Medical Center, Louisville, Kentucky

Received 21 September 2010; 

accepted 25 November 2010. 

Available online 13 February 2011.

Abstract

Patients undergoing treatment for head and neck cancers have a myriad of distressing symptoms and treatment side effects which significantly alter communication and lower quality of life. Telehealth technology has demonstrated promise in improving patient–provider communication by delivering supportive educational content and guidance to patients in their homes. A telehealth intervention using a simple telemessaging device was developed to provide daily education, guidance, and encouragement for patients undergoing initial treatment of head and neck cancer. The goal of this article is to report the feasibility and acceptance of the intervention using both quantitative and qualitative measures. No eligible patients declined participation based on technology issues. Participants completed the intervention for over 86% of the expected days of use. Direct nursing contact was seldom needed during the study period. Satisfaction with the technology and the intervention was very high. In this study a telehealth intervention was shown to be feasible, well accepted, and regularly used by patients experiencing extreme symptom burden and declining quality of life as a result of aggressive treatment for head and neck cancer.

Article Outline

Methods

Design

Site

Sample

Description of the Intervention

Measures

Accrual rate

Utilization

Nurse-initiated contacts with participants and/or clinicians

Satisfaction ratings

Narrative data

Poststudy survey

Demographic and medical information

Outcome measures

Data Analysis

Results

Description of Participants

Feasibility and Acceptability

Accrual rate

Device utilization

Nurse-initiated contacts with participants and/or clinicians

Satisfaction ratings

Narrative comments

Poststudy survey

Outcome Measures

Correlations

Discussion
Conclusions
Acknowledgements
References

Treatment for head and neck cancer is most often a rigorous regimen of combination therapies, producing a multitude of distressing symptoms and side effects. While it is nearly impossible to circumvent the physical and psychosocial insults caused by such treatment, some interventions directed toward educating and supporting patients during active treatment have met with success.[1], [2], [3] and [4] Conversely, other efforts have demonstrated little impact[5] and [6] or have been poorly received,

7

> more Treatment-Related Side Effects articles




Current Issue


The Journal of Supportive Oncology Focused on symptom and side-effect management, communication issues, and end-of-life care for patients with cancer.



For past issues, click here »


calendar
Jun 1 - 5
Chicago, IL
American Society of Clinical Oncology (ASCO): Annual Meeting
Jun 14 - 17
Amsterdam,
European Hematology Association (EHA): Annual Congress
Jun 18 - 21
Lake Tahoe, NV
American Association for Cancer Research (AACR): Pancreatic Cancer: Progress and Challenges
Jun 20 - 22
Milan,
European Institute of Oncology (IEO): 14th Milan Breast Cancer Conference
Jun 25 - 26
London,
Teenage Cancer Trust (TCT): International Conference
Jun 27 - 30
Barcelona,
European Society for Medical Oncology (ESMO) Conference: World Congress on Gastrointestinal Cancer
Jun 27 - 30
Boston, MA
American Association for Cancer Research (AACR): Chemical Systems Biology
Jun 28 - 30
New York, NY
Multinational Association of Supportive Care in Cancer (MASCC)/ International Society of Oral Oncology (ISOO): International Symposium
Jun 28 - 29
Paris,
WIN 2012 Symposium
Jul 7 - 10
Barcelona,
22nd Biennial Congress of the European Association for Cancer Research
More Calendar »